Citizens Business Bank Reduces Position in Danaher Co. (NYSE:DHR)

Citizens Business Bank decreased its holdings in Danaher Co. (NYSE:DHR) by 3.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,619 shares of the conglomerate’s stock after selling 472 shares during the period. Citizens Business Bank’s holdings in Danaher were worth $2,919,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of DHR. Brookstone Capital Management grew its position in shares of Danaher by 38.1% in the third quarter. Brookstone Capital Management now owns 10,032 shares of the conglomerate’s stock valued at $2,489,000 after purchasing an additional 2,767 shares in the last quarter. FAS Wealth Partners Inc. boosted its stake in Danaher by 12.1% during the third quarter. FAS Wealth Partners Inc. now owns 5,146 shares of the conglomerate’s stock valued at $1,277,000 after buying an additional 556 shares during the period. Defender Capital LLC. grew its position in Danaher by 6.2% during the third quarter. Defender Capital LLC. now owns 152,962 shares of the conglomerate’s stock worth $37,950,000 after buying an additional 8,880 shares in the last quarter. Accurate Wealth Management LLC increased its stake in Danaher by 32.7% in the 3rd quarter. Accurate Wealth Management LLC now owns 1,555 shares of the conglomerate’s stock worth $386,000 after acquiring an additional 383 shares during the last quarter. Finally, Aua Capital Management LLC raised its stake in Danaher by 19.1% in the third quarter. Aua Capital Management LLC now owns 1,030 shares of the conglomerate’s stock valued at $256,000 after purchasing an additional 165 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 3,289 shares of Danaher stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the sale, the director now directly owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the completion of the transaction, the senior vice president now directly owns 29,830 shares in the company, valued at approximately $7,457,798.30. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teri List sold 3,289 shares of Danaher stock in a transaction dated Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at $4,898,360.32. The disclosure for this sale can be found here. Insiders have sold 106,565 shares of company stock worth $26,641,364 over the last 90 days. 10.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Royal Bank of Canada lifted their price target on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, January 31st. Citigroup lifted their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. TD Cowen upped their price target on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research report on Wednesday, April 24th. Finally, KeyCorp lifted their price objective on Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $269.64.

Danaher Trading Down 0.1 %

NYSE DHR traded down $0.16 on Tuesday, hitting $246.66. The company’s stock had a trading volume of 3,940,969 shares, compared to its average volume of 2,785,271. The firm has a market cap of $182.70 billion, a P/E ratio of 41.83, a PEG ratio of 3.80 and a beta of 0.83. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $259.00. The company’s 50-day simple moving average is $248.80 and its 200 day simple moving average is $231.53. The company has a current ratio of 1.85, a quick ratio of 1.51 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm’s revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.36 earnings per share. Research analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a dividend of $0.27 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is presently 18.31%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.